• Join our community!

    Do you have questions about celiac disease or the gluten-free diet?

  • Ads by Google:
     




    Get email alerts Subscribe to Celiac.com's FREE weekly eNewsletter

    Ads by Google:



       Get email alertsSubscribe to Celiac.com's FREE weekly eNewsletter

  • Member Statistics

    77,651
    Total Members
    3,093
    Most Online
    Kitty11
    Newest Member
    Kitty11
    Joined
  • 0

    Increased Risk of End-stage Renal Disease in People with Celiac Disease


    Jefferson Adams

    Celiac.com 09/19/2011 - Rates of end-stage renal disease are rising globally, and even though doctors often see elevated levels of celiac disease autoantibodies in renal disease, they do not yet fully understand the role of biopsy-verified celiac disease as a risk factor for end-stage renal disease.


    Ads by Google:




    ARTICLE CONTINUES BELOW ADS
    Ads by Google:



    To gain a gleaner picture of possible connections, a team of researchers based in Sweden conducted a study of end-stage renal disease in individuals with celiac disease.

    The research team included A. Welander, K. G. Prütz, M. Fored, J. F. Ludvigsson. They are affiliated with the Department of Medicine at the Karolinska Institutet of the Karolinska University Hospital in Stockholm, Sweden.

    To identify individuals for their population-based prospective cohort study, the team used small-intestinal biopsy reports. They found data on 29,050 individuals with celiac disease (Marsh III) obtained between July 1969 and February 2008 in Sweden's 28 pathology departments.

    The team defined end-stage renal disease as the need for renal dialysis or renal transplant in accordance with the international classification of disease and procedure codes in Swedish patient registers.

    They used Cox regression to compare the risk of end-stage renal disease in individuals with celiac disease against the risk for age- and sex-matched reference individuals.

    They found that, on follow-up, 90 individuals with celiac disease had developed end-stage renal disease, compared with a projected number of 31.

    This means that people with celiac disease face an end-stage renal disease risk estimate of 2.87 (95% CI 2.22 to 3.71, p<0.001).  Adjusting for diabetes mellitus lowered that risk estimate only slightly, to 2.52 (95% CI 1.92 to 3.31).

    When the team excluded people with prior urinary/renal disorders, the risk estimate for end-stage renal disease in people with celiac disease was 2.47 (95% CI 1.80 to 3.40).

    However, once the team restricted the outcome measure to end-stage renal confirmed by independent data from the Swedish Renal Registry (SRR), the overall risk estimate increased to 3.20 (95% CI 2.39 to 4.28).

    The results of this study show that people with biopsy-verified celiac disease face a higher risk of developing end-stage renal disease.

    Source:

    0


    User Feedback

    Recommended Comments

    Guest Gail Cleveland

    Posted

    I wonder if this is true with treated celiac patients who's blood tests are coming back very good while on the gluten-free diet?

    Share this comment


    Link to comment
    Share on other sites


    Your content will need to be approved by a moderator

    Guest
    You are commenting as a guest. If you have an account, please sign in.
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • Ads by Google:

  • About Me

    Jefferson Adams is a freelance writer living in San Francisco. He has covered Health News for Examiner.com, and provided health and medical content for Sharecare.com. His work has appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden's Ferry Review, Huffington Post, the Mississippi Review, and Slate, among others.

  • Popular Contributors

  • Ads by Google:

  • Who's Online   14 Members, 0 Anonymous, 699 Guests (See full list)

  • Related Articles

    Jefferson Adams
    Celiac.com 07/10/2007 - This study demonstrates that people with celiac disease face an elevated risk of glomerulonephritis. Multiple studies have shown higher levels of celiac disease auto-antibodies in patients with renal disease; and certain renal disease will improve on a low-antigenic diet that is gluten-free. Not much is understood about the risk of severe renal disease such as renal failure in individuals with celiac disease. In a general population based cohort study, a team of researchers set out to assess the individuals with celiac disease for any form of glomerulonephritis (acute, chronic and non- specified), chronic glomerulonephritis and renal replacement therapy including dialysis treatment and kidney transplantation.
    The research team was made up of Anders Ekbom, Michael Fored, Jonas F. Ludvigsson, Johnny Ludvigsson, Nders ekbom, Ola Ole, & Scott M. Montgomery.
    They looked at data from 14,336 patients who were diagnosed with celiac disease between 1964 and 2003. Patients were chosen from the Swedish Hospital Discharge Registry. They established a control group of 69,875 individuals matched for age, calendar year, sex and county.
    Higher Risk of Glomerulonephritis for Celiac Patients
    The results showed that patients with celiac disease face an increased risk of developing chronic renal disease, and may also be at a face a slightly higher risk for any form of glomerulonephritis.
    Nephrology Dialysis Transplantation 2006 21(7):1809-1815
    health writer who lives in San Francisco and is a frequent author of articles for Celiac.com.

    Jefferson Adams
    Celiac.com 04/27/2012 - Urinary stone disease is condition often caused by malabsorption. Because of its high prevalence and incidence, doctors regard it as a serious issue. However, there are few population-based studies on the risk of urinary stone disease in patients with celiac disease.
    A team of medical researchers recently studied the risk of urinary stone disease in people with celiac disease. The research team included J. F. Ludvigsson, F. Zingone, M. Fored, C. Ciacci and M. Cirillo.
    For their population-based cohort study, the team used small intestinal biopsy reports gathered from all 28 Swedish pathology departments from 1969 to 2008. In all, the team found 28,735 patients with celiac disease, all with the equivalent of Marsh 3 villous atrophy.
    They then isolated a control group of 142,177 people from the Swedish general population. They matched patients and control subjects for age, gender, age, county and calendar year.
    Using Cox regression, they estimated hazard ratios for future urinary stone disease. Using conditional logistic regression they then calculated odds ratios for urinary stone disease before celiac disease diagnosis.
    The team used Swedish National Patient Register data on inpatient care, outpatient care and day surgery to find cases of urinary stone disease.
    During follow-up, a total of 314 people with celiac disease developed urinary stone disease, compared with 1142 from the control group.
    These numbers indicated that people with celiac disease face a 27% increased risk of urinary stone disease [95% confidence interval (CI) = 1.12–1.44].
    For celiac disease, patients the absolute risk of developing urinary stone disease was 107 cases per 100,000 person-years; which corresponds to an excess risk of 23 cases per 100,000 person years.
    Men and women faced similar risk levels, and showed no difference with respect to age at celiac disease diagnosis.
    Using conditional logistic regression the team found that celiac disease patients also faced a moderately higher risk of prior urinary stone disease (OR = 1.19; 95% CI = 1.06–1.33).
    The study indicates that people with celiac disease face a slightly higher risk of urinary stone disease both before and after celiac disease diagnosis.
    Source:
    Alimentary Pharmacology & Therapeutics. 2012;35(4):477-484.

    Jefferson Adams
    Celiac.com 05/21/2014 - A team of researchers recently studied the risk of renal disease in patients with both type 1 diabetes (T1D) and celiac disease.
    The research team included K. Mollazadegan, M. Fored, S. Lundberg, J. Ludvigsson, A. Ekbom, S.M. Montgomery, and J.F. Ludvigsson, with the Clinical Epidemiology Unit of the Department of Medicine at the Karolinska Institutet in Stockholm, Sweden.
    For their study, the team used the Swedish Patient Register to review data on cases of T1D recorded at or before 30 years of age between 1964 and 2009.
    The team used biopsy reports from 28 pathology departments in Sweden between 1969 and 2008 to gather data on patients with celiac disease with villous atrophy (Marsh stage 3). They found 954 patients with both T1D and celiac disease. They age and sex-matched each patient with T1D + celiac disease to five reference individuals with T1D only (n = 4,579).
    They used Cox regression to estimate the following risks of both chronic and end-stage renal disease in patients with celiac disease + T1D compared with T1D patients only. They found that forty-one (4.3%) patients with celiac disease + T1D and 143 (3.1%) patients with T1D only developed chronic renal disease. This corresponded to an HR of 1.43 for chronic renal disease (95% CI 0.94, 2.17) in patients with celiac disease + T1D compared with T1D only.
    In addition, for end-stage renal disease there was a positive (albeit statistically non-significant) HR of 2.54 (95% CI 0.45, 14.2). For chronic renal disease, the excess risk was more pronounced after >10 years of celiac disease (HR 2.03, 95% CI 1.08, 3.79).
    Overall the two groups showed similar risk estimates when the cohort was restricted to T1D patients who had an inpatient diagnosis of T1D; those who had never received oral glucose-lowering medication; and (3) those who had not received their first diabetes diagnosis during pregnancy.
    The team found no excess risk of chronic renal disease in patients with T1D and celiac disease. Interestingly, a sub-analysis did show a connection between long-term celiac disease and chronic renal disease in people with T1D.
    Source:
    Diabetologia. 2014 Mar 25. 

  • Recent Articles

    Jefferson Adams
    Celiac.com 06/21/2018 - Would you buy a house advertised as ‘gluten-free’? Yes, there really is such a house for sale. 
    It seems a Phoenix realtor Mike D’Elena is hoping that his trendy claim will catch the eye of a buyer hungry to avoid gluten, or, at least one with a sense of humor. D’Elena said he crafted the ads as a way to “be funny and to draw attention.” The idea, D’Elena said, is to “make it memorable.” 
    Though D’Elena’s marketing seeks to capitalizes on the gluten-free trend, he knows Celiac disease is a serious health issue for some people. “[W]e’re not here to offend anybody….this is just something we're just trying to do to draw attention and do what's best for our clients," he said. 
    Still, the signs seem to be working. D'elena had fielded six offers within a few days of listing the west Phoenix home.
    "Buying can sometimes be the most stressful thing you do in your entire life so why not have some fun with it," he said. 
    What do you think? Clever? Funny?
    Read more at Arizonafamily.com.

    Advertising Banner-Ads
    Bakery On Main started in the small bakery of a natural foods market on Main Street in Glastonbury, Connecticut. Founder Michael Smulders listened when his customers with Celiac Disease would mention the lack of good tasting, gluten-free options available to them. Upon learning this, he believed that nobody should have to suffer due to any kind of food allergy or dietary need. From then on, his mission became creating delicious and fearlessly unique gluten-free products that were clean and great tasting, while still being safe for his Celiac customers!
    Premium ingredients, bakeshop delicious recipes, and happy customers were our inspiration from the beginning— and are still the cornerstones of Bakery On Main today. We are a fiercely ethical company that believes in integrity and feels that happiness and wholesome, great tasting food should be harmonious. We strive for that in everything we bake in our dedicated gluten-free facility that is GFCO Certified and SQF Level 3 Certified. We use only natural, NON-GMO Project Verified ingredients and all of our products are certified Kosher Parve, dairy and casein free, and we have recently introduced certified Organic items as well! 
    Our passion is to bake the very best products while bringing happiness to our customers, each other, and all those we meet!
    We are available during normal business hours at: 1-888-533-8118 EST.
    To learn more about us at: visit our site.

    Jefferson Adams
    Celiac.com 06/20/2018 - Currently, the only way to manage celiac disease is to eliminate gluten from the diet. That could be set to change as clinical trials begin in Australia for a new vaccine that aims to switch off the immune response to gluten. 
    The trials are set to begin at Australia’s University of the Sunshine Coast Clinical Trials Centre. The vaccine is designed to allow people with celiac disease to consume gluten with no adverse effects. A successful vaccine could be the beginning of the end for the gluten-free diet as the only currently viable treatment for celiac disease. That could be a massive breakthrough for people with celiac disease.
    USC’s Clinical Trials Centre Director Lucas Litewka said trial participants would receive an injection of the vaccine twice a week for seven weeks. The trials will be conducted alongside gastroenterologist Dr. James Daveson, who called the vaccine “a very exciting potential new therapy that has been undergoing clinical trials for several years now.”
    Dr. Daveson said the investigational vaccine might potentially restore gluten tolerance to people with celiac disease.The trial is open to adults between the ages of 18 and 70 who have clinically diagnosed celiac disease, and have followed a strict gluten-free diet for at least 12 months. Anyone interested in participating can go to www.joinourtrials.com.
    Read more at the website for Australia’s University of the Sunshine Coast Clinical Trials Centre.

    Source:
    FoodProcessing.com.au

    Jefferson Adams
    Celiac.com 06/19/2018 - Could baking soda help reduce the inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease? Scientists at the Medical College of Georgia at Augusta University say that a daily dose of baking soda may in fact help reduce inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease.
    Those scientists recently gathered some of the first evidence to show that cheap, over-the-counter antacids can prompt the spleen to promote an anti-inflammatory environment that could be helpful in combating inflammatory disease.
    A type of cell called mesothelial cells line our body cavities, like the digestive tract. They have little fingers, called microvilli, that sense the environment, and warn the organs they cover that there is an invader and an immune response is needed.
    The team’s data shows that when rats or healthy people drink a solution of baking soda, the stomach makes more acid, which causes mesothelial cells on the outside of the spleen to tell the spleen to go easy on the immune response.  "It's most likely a hamburger not a bacterial infection," is basically the message, says Dr. Paul O'Connor, renal physiologist in the MCG Department of Physiology at Augusta University and the study's corresponding author.
    That message, which is transmitted with help from a chemical messenger called acetylcholine, seems to encourage the gut to shift against inflammation, say the scientists.
    In patients who drank water with baking soda for two weeks, immune cells called macrophages, shifted from primarily those that promote inflammation, called M1, to those that reduce it, called M2. "The shift from inflammatory to an anti-inflammatory profile is happening everywhere," O'Connor says. "We saw it in the kidneys, we saw it in the spleen, now we see it in the peripheral blood."
    O'Connor hopes drinking baking soda can one day produce similar results for people with autoimmune disease. "You are not really turning anything off or on, you are just pushing it toward one side by giving an anti-inflammatory stimulus," he says, in this case, away from harmful inflammation. "It's potentially a really safe way to treat inflammatory disease."
    The research was funded by the National Institutes of Health.
    Read more at: Sciencedaily.com

    Jefferson Adams
    Celiac.com 06/18/2018 - Celiac disease has been mainly associated with Caucasian populations in Northern Europe, and their descendants in other countries, but new scientific evidence is beginning to challenge that view. Still, the exact global prevalence of celiac disease remains unknown.  To get better data on that issue, a team of researchers recently conducted a comprehensive review and meta-analysis to get a reasonably accurate estimate the global prevalence of celiac disease. 
    The research team included P Singh, A Arora, TA Strand, DA Leffler, C Catassi, PH Green, CP Kelly, V Ahuja, and GK Makharia. They are variously affiliated with the Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Lady Hardinge Medical College, New Delhi, India; Innlandet Hospital Trust, Lillehammer, Norway; Centre for International Health, University of Bergen, Bergen, Norway; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Gastroenterology Research and Development, Takeda Pharmaceuticals Inc, Cambridge, MA; Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy; Department of Medicine, Columbia University Medical Center, New York, New York; USA Celiac Disease Center, Columbia University Medical Center, New York, New York; and the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
    For their review, the team searched Medline, PubMed, and EMBASE for the keywords ‘celiac disease,’ ‘celiac,’ ‘tissue transglutaminase antibody,’ ‘anti-endomysium antibody,’ ‘endomysial antibody,’ and ‘prevalence’ for studies published from January 1991 through March 2016. 
    The team cross-referenced each article with the words ‘Asia,’ ‘Europe,’ ‘Africa,’ ‘South America,’ ‘North America,’ and ‘Australia.’ They defined celiac diagnosis based on European Society of Pediatric Gastroenterology, Hepatology, and Nutrition guidelines. The team used 96 articles of 3,843 articles in their final analysis.
    Overall global prevalence of celiac disease was 1.4% in 275,818 individuals, based on positive blood tests for anti-tissue transglutaminase and/or anti-endomysial antibodies. The pooled global prevalence of biopsy-confirmed celiac disease was 0.7% in 138,792 individuals. That means that numerous people with celiac disease potentially remain undiagnosed.
    Rates of celiac disease were 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania; the prevalence was 0.6% in female vs 0.4% males. Celiac disease was significantly more common in children than adults.
    This systematic review and meta-analysis showed celiac disease to be reported worldwide. Blood test data shows celiac disease rate of 1.4%, while biopsy data shows 0.7%. The prevalence of celiac disease varies with sex, age, and location. 
    This review demonstrates a need for more comprehensive population-based studies of celiac disease in numerous countries.  The 1.4% rate indicates that there are 91.2 million people worldwide with celiac disease, and 3.9 million are in the U.S.A.
    Source:
    Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037.